Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

General Description

Monte Rosa Therapeutics

Youtube Subscribe

...

Ticker: GLUE

Sector: Biotechnology

Monte Rosa Therapeutics, Inc. engages in the development of novel small molecule precision medicines. The company develops an orally bioavailable molecular glue degrader for GSPT1, a a translation termination factor for the treatment of My.
...
...
Extended Summary

Monte Rosa Therapeutics

Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. The company develops an orally bioavailable molecular glue degrader for GSPT1, a a translation termination factor for the treatment of Myc-driven cancers. It also develops CDK2 to treat ovarian, uterine, and breast cancers; NEK7 for the treatment of inflammatory diseases, such as gout and Crohn's disease, neurodegenerative disease, diabetes, and liver disease; VAV1, a target protein for autoimmune diseases; and a therapeutically-relevant protein in hemoglobinopathies. The company was incorporated in 2019 and is headquartered in Boston, Massachusetts.

Related Results

...
February 20, 2024 22:13 (London Time)

Monte Rosa Therapeutics

Monte Rosa Therapeutics is a biotechnology company developing small molecules to degrade disease-related proteins. MRT-2359 by monte rosa therapeuti…
Sector: Biotechnology
Ticker: GLUE
Sentiment: -0.8176
MarketCap: 298,482,897.0
High: 5.99 Low: 5.42

Open: 5.85 Close: 5.55 Change: -0.3

Read more →
...
May 13, 2023 23:17 (London Time)

Monte Rosa Therapeutics

Monte Rosa Therapeutics reported quarterly losses of $0.65 per share. Credit Suisse reiterated a Hold rating on Monte RosaTherapeutics (GLUE – Resea…
Sector: Biotechnology
Ticker: GLUE
Sentiment: -0.1027
MarketCap: 401,288,938.0
High: 6.13 Low: 5.6

Open: 5.72 Close: 5.68 Change: -0.04

Read more →
Search
Happening Now
Categories